STAT3 and plasma cell myeloma: Their inhibitory activity most likely arises from a combination of binding directly to Stat3 as well as interfering with other cellular processes, and although compounds such as STA-21, S31-M2001 or S3I-201 suppress the growth of breast cancer, myeloma and melanoma cell lines in xenograph model, the clinical utility of these molecules still awaits confirmation.